Reports
Sale
Global Gastroenterology Market Size, Share, Forecast: By Product Type: Drugs, Medical Devices, Diagnostic Tools, Others; By Indications: Inflammatory Bowel Disease (IBD), Gastroesophageal Reflux Disease (GERD), Colorectal Cancer, Liver Diseases, Pancreatic Disorders, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Gastroenterology Market Outlook
The global gastroenterology market size attained a value of USD 54.59 billion in 2023. The market is anticipated to grow at a CAGR of 6.2% during the forecast period of 2024-2032. The market is likely to attain a value of USD 93.80 billion by 2032, likely to be driven by the rising gastrointestinal cases across the globe.
Gastroenterology: Introduction
A medical condition involving stomach and other organs of the digestive process are known as gastric conditions. The digestive system includes gastrointestinal tract, which is also known as the GI tract, comprising the esophagus, stomach, small intestine, large intestine, and the accessory organs of digestion, which include the pancreas, gallbladder, and liver. The branch of medicine which deals with the examination, diagnosis, and treatment of the issues related to these parts is known as gastroenterology.
In order to move material through the GI tract, digest it, absorb nutrients for use by the body, and remove waste from the body through defecation, the digestive system must function efficiently. Due to the similarity of many of the symptoms and the time-consuming nature of the diagnostic procedures, diagnosing a gastrointestinal illness may be difficult.
Global Gastroenterology Market Analysis
The increasing awareness among people about the importance of early diagnosis of gastrointestinal disorders and about available treatments is directly influencing the market growth. The increasing shift towards minimally invasive surgical procedures is also driving the market growth as people are preferring them more among other approaches. The continuous development in the diagnosis procedure of gastrointestinal disorders is also propelling the market growth.
The integration and development of technologically advanced imaging techniques, such as fluoroscopy, is also adding up significant growth to the overall gastroenterology market share. The continuous development of endoscopy devices is anticipated to accelerate the market growth further. The increasing preference for personalized treatment approaches is also expected to drive the market demand as a personalized molecular diagnosis will enable the healthcare professional to retrieve more useful diagnosis data for individuals, with the ability to produce a personalized prognosis and treatment approaches.
The increasing number of approvals is also expected to escalate the market growth. For example, the Vowst has been approved by the FDA as the first oral microbiota biotherapeutic for recurrent C. difficile infection in adults, following antibacterial treatment. The increasing government initiatives towards accessible healthcare is also aiding the growth of the market. The first drug to cure functional constipation in children and the first oral product to cure moderately to severely active Crohn’s disease has also been approved by the FDA recently, further escalating the global gastroenterology market development. There has been a surge in the market due to increase in development and manufacturing gastrointestinal drugs globally, which is further anticipated to propel the market growth. Various drugs are currently in the pipeline to be approved, including 16 oral drugs and six injectables in the pipeline. There are six drugs for breast cancer and three for non-small cell lung cancer (NSCLC) in the pipeline. Once approved, these drugs can potentially improve the treatment landcape.
Global Gastroenterology Market Segmentations
Market Breakup by Product Type
- Drugs
- Proton Pump Inhibitor
- H2 Antihistamine
- Others
- Medical Devices
- Endoscopy Devices
- Therapeutic devices
- Others
- Diagnostic Tools
- Others
Market Breakup by Indications
- Inflammatory Bowel Disease (IBD)
- Gastroesophageal Reflux Disease (GERD)
- Colorectal Cancer
- Liver Diseases
- Pancreatic Disorders
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Gastroenterology Market Overview
The market is experiencing significant growth due to the rising prevalence of pancreatic disorders across the globe. People are adapting to sedentary lifestyle, including unhealthy eating habits and non-active lifestyle, which leads to digestion issues, gastrointestinal issues, among others. The increasing numbers of gastrointestinal disorders are likely to drive the market growth further in the coming years.
The growth of the market is also driven by the increasing geriatric population as with growing age they get more susceptible to them due to weakened immune system. The increasing healthcare expenditure of countries globally is also driving the global gastroenterology market growth as the patient pool is large. The increasing demand for more cost effective and accessible treatments for gastrointestinal disorders such as inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and colorectal cancer, is a key factor influencing the market growth.
Gastroenterology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Johnson & Johnson
- AbbVie Inc.
- Salix Pharmaceuticals
- GlaxoSmithKline Plc.
- ALLERGAN
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Astellas Pharma US, Inc.
- Pfizer Inc.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Indications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Gastroenterology Market Overview
3.1 Global Gastroenterology Market Historical Value (2017-2023)
3.2 Global Gastroenterology Market Forecast Value (2024-2032)
4 Global Gastroenterology Market Landscape
4.1 Global Gastroenterology Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Gastroenterology Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Applications
5 Global Gastroenterology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Gastroenterology Market Segmentation
6.1 Global Gastroenterology Market by Product Type
6.1.1 Market Overview
6.1.2 Drugs
6.1.2.1 Proton Pump Inhibitor
6.1.2.2 H2 Antihistamine
6.1.2.3 Others
6.1.3 Medical Devices
6.1.3.1 Endoscopy Devices
6.1.3.2 Therapeutic devices
6.1.3.3 Others
6.1.4 Diagnostic Tools
6.1.5 Others
6.2 Global Gastroenterology Market by Indications
6.2.1 Market Overview
6.2.2 Inflammatory Bowel Disease (IBD)
6.2.3 Gastroesophageal Reflux Disease (GERD)
6.2.4 Colorectal Cancer
6.2.5 Liver Diseases
6.2.6 Pancreatic Disorders
6.2.7 Others
6.3 Global Gastroenterology Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centers
6.3.4 Specialty Clinics
6.3.5 Research Institutes
6.3.6 Others
6.4 Global Gastroenterology Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Gastroenterology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Gastroenterology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Gastroenterology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Gastroenterology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Gastroenterology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Johnson & Johnson
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 AbbVie Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Salix Pharmaceuticals
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 GlaxoSmithKline Plc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 ALLERGAN
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Takeda Pharmaceutical Company Limited
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 AstraZeneca
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Astellas Pharma US, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Pfizer Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Gastroenterology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 6.2% during the forecast period of 2024-2032.
The increasing number of gastrointestinal disorders and increasing healthcare expenditure among people across the globe is a major factor driving the market growth.
The increasing technological development and increased approvals for new drugs in the pipeline are among major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The types of gastroenterology products include drugs, medical devices, and diagnostic tools, among others.
The indications include inflammatory bowel disease (IBD) and gastroesophageal reflux disease (GERD), colorectal cancer, liver diseases, and pancreatic disorders, among others.
The end users in the market include hospitals, ambulatory surgical centers, specialty clinics, and research institutes, among others.
Key players involved in the market are Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, GlaxoSmithKline Plc., ALLERGAN, AstraZeneca, Astellas Pharma US, Inc., Pfizer Inc., and Takeda Pharmaceutical Company Limited
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER